Michael I. Nishimura

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

C. Marcela Díaz‐Montero, Mohamed L. Salem, Michael I. Nishimura et al. · Cancer Immunology Immunotherapy · 2008 · 1.2K citations

Clinical Cancer Stage, Tumor Biology, Medicine +10

Efficient Transfer of a Tumor Antigen-Reactive TCR to Human Peripheral Blood Lymphocytes Confers Anti-Tumor Reactivity

Timothy M. Clay, Mary Custer, Jessica Sachs et al. · The Journal of Immunology · 1999 · 405 citations · Full text

Immunology, Confers Anti-tumor Reactivity, Antigen Processing +20

Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic Melanoma

Mark E. Dudley, John R. Wunderlich, Michael I. Nishimura et al. · Journal of Immunotherapy · 2001 · 354 citations

Recognition of Host Immune Activation by <i>Pseudomonas aeruginosa</i>

Licheng Wu, Oscar Estrada, Olga Zaborina et al. · Science · 2005 · 322 citations

Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity

Rachel H. McMahan, Lucy Golden‐Mason, Michael I. Nishimura et al. · Journal of Clinical Investigation · 2010 · 297 citations · Full text

Tim-3 Expression, Viral Persistence, Hepatology +15